Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
about
Febrile Neutropenia with Thrombocytopenia after Infliximab Induction in a Patient with Ulcerative Colitis.Severe Henoch-Schönlein purpura with infliximab for ulcerative colitisHistologic markers of inflammation in patients with ulcerative colitis in clinical remission.Randomised clinical study: discrepancies between patient-reported outcomes and endoscopic appearance in moderate to severe ulcerative colitis.The positioning of colectomy in the treatment of ulcerative colitis in the era of biologic therapy.Advances in the medical management of paediatric IBD.Management of inflammatory bowel disease in poor responders to infliximab.Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future.Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.Long-term efficacy and safety of azathioprine in ulcerative colitis.Tumor necrosis factor alpha blocking agents as treatment for ulcerative colitis intolerant or refractory to conventional medical therapy: a meta-analysisOptimizing biologic therapy for treatment of inflammatory bowel disease.Long-Term Outcome of IPAA in Patients Presenting with Fulminant Ulcerative Colitis: A Matched Cohort Study.Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis.
P2860
Q33437403-D059901A-9094-4185-AE24-7DC4116FD1B0Q35625482-41377768-60D3-4CF6-88EC-EA5181C84F23Q37122161-B2F027F6-1BD8-4551-8FAD-F3B7825A53ECQ37308977-BE00BF36-7C4A-4BDC-9CE8-2F30E3B3DCEAQ38121000-95459637-6A71-41CD-A937-76CFC502ACDCQ38130044-76885EB0-ACA2-4FC2-A775-8CE2698CE766Q38254573-C54E54EC-4925-4515-874C-3635F3ECD49BQ38647797-024FD5B6-1A66-4276-854E-B4CB962E42FEQ38816194-765FD704-9ABF-4EC5-A325-7969CBEC65D1Q40926333-0CB55EBB-8BF2-4701-885F-FF92C978EBD2Q41678376-EE2C57EE-98D6-4535-9670-64F90110850FQ41894047-697DCFF5-0116-4A61-938F-6ECCD5CC2888Q42066696-8EF2FE3A-6F32-4CDD-BA2D-BD4363ED47A0Q43334496-5BEE0D0C-3840-4711-8B28-30E5AA7A095EQ44104683-61401CFD-97B2-4A43-9DB5-114D63E4F9A1Q47442388-00EB523D-3508-4B9B-8404-A855D57D5F0BQ54092608-B0369636-E50B-4F36-9E4F-D45EEBBFA867
P2860
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Recommendations for the treatm ...... erology expert group consensus
@ast
Recommendations for the treatm ...... erology expert group consensus
@en
Recommendations for the treatm ...... erology expert group consensus
@nl
type
label
Recommendations for the treatm ...... erology expert group consensus
@ast
Recommendations for the treatm ...... erology expert group consensus
@en
Recommendations for the treatm ...... erology expert group consensus
@nl
prefLabel
Recommendations for the treatm ...... erology expert group consensus
@ast
Recommendations for the treatm ...... erology expert group consensus
@en
Recommendations for the treatm ...... erology expert group consensus
@nl
P2093
P50
P3181
P1476
Recommendations for the treatm ...... erology expert group consensus
@en
P2093
C. Janneke van der Woude
Dario Sorrentino
Julian Panes
Mark S. Silverberg
Pierre Michetti
Ragnar Befrits
Remo Panaccione
Stefan Schreiber
Subrata Ghosh
Thomas Ochsenkühn
P304
P3181
P356
10.1016/J.CROHNS.2011.11.001
P407
P577
2012-03-01T00:00:00Z